Vincent Puthod

Vincent Puthod is a seasoned professional with extensive experience in the biotechnology and pharmaceutical industries. Currently serving as Country Manager for France at Veracyte, Inc. since January 2020, Vincent has played a pivotal role in the acquisition of NanoString Diagnostics, including the Prosigna breast cancer prognostic test. Prior to this, Vincent held positions at NanoString Technologies, where responsibilities included managing operations across France and the UK, Ireland, Benelux, and Switzerland, focusing on genomics in oncology. Earlier experience includes leadership roles at Labolife, Takeda Europe, BMS, MSD, and Fournier Pharma, where Vincent contributed to marketing, commercial development, and product management across various therapeutic areas. Vincent's educational background includes a Master's degree in Business/Commerce from Golden Gate University and advanced studies at INSEAD.